Skip to content
DefDex

Federal award

BANYAN BIOMARKERS, INC.

W81XWH10C0251

Contract

Obligated and Ceiling

Obligated (net)
$57,333,245.56
Ceiling (potential value, not spending)
$57,333,245.56
Current value
$57,333,245.56
Gross positive obligations
$75,544,328.19

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
BANYAN BIOMARKERS, INC. · UXMCAUMK9MP7
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
BANYAN BIOMARKERS, INC. · UXMCAUMK9MP7
Awarding agency
Department of War · sub-agency 2100 · office W81XWH
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN93 · R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT)
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
W81XWH10C0251
Award type code
D
Actions
44 · Sep 28, 2010 to Mar 1, 2019
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History44

Award actions
DateFYModAction typeObligationCompany in company totals
Mar 1, 2019FY2019P00043C−$0.02
—
Dec 28, 2018FY2019P00042C−$4,563.61
—
Aug 7, 2018FY2018P00041C−$6,611,674.00
—
Jan 2, 2018FY2018P00040C$902,568.00
—
Oct 30, 2017FY2018P00039B$0.00
—
Aug 31, 2017FY2017P00038M$0.00
—
Aug 28, 2017FY2017P00037C$2,680,160.19
—
Jul 31, 2017FY2017P00036M$0.00
—
Jul 19, 2017FY2017P00035B$1,171,000.00
—
May 23, 2017FY2017P00034M$0.00
—
Mar 21, 2017FY2017P00033M$0.00
—
Mar 7, 2017FY2017P00031M$0.00
—
Mar 7, 2017FY2017P00032M$0.00
—
Feb 15, 2017FY2017P00030M$0.00
—
Dec 16, 2016FY2017P00029B$0.00
—
Sep 12, 2016FY2016P00028M$0.00
—
Sep 1, 2016FY2016P00027M$0.00
—
Dec 21, 2015FY2016P00026C$13,313,134.59
—
Oct 15, 2015FY2016P00025M$0.00
—
Sep 24, 2015FY2015P00024M$0.00
—
Sep 18, 2015FY2015P00023M$593,489.52
—
Aug 19, 2015FY2015P00022C$1,956,243.89
—
Jul 28, 2015FY2015P00021B$3,333,400.00
—
Nov 13, 2014FY2015P00020B$0.00
—
May 23, 2014FY2014P00019B$1,542,959.00
—
May 9, 2014FY2014P00018C−$1,594,845.00
—
May 1, 2014FY2014P00017M$0.00
—
Mar 19, 2014FY2014P00016A$65,773.00
—
Sep 18, 2013FY2013P00015B$12,913,000.00
—
Apr 9, 2013FY2013P00014C$6,203,773.71
—
Jan 23, 2013FY2013P00013M$0.00
—
Jan 17, 2013FY2013P00012M$0.00
—
Jan 7, 2013FY2013P00011M$0.00
—
Nov 7, 2012FY2013P00010M$0.00
—
Sep 27, 2012FY2012P00009C$3,979,792.00
—
Aug 20, 2012FY2012P00008M$0.00
—
Jan 9, 2012FY2012P00007M$0.00
—
Sep 26, 2011FY2011P00006C$1,600,000.00
—
Jun 28, 2011FY2011P00005C−$10,000,000.00
—
May 23, 2011FY2011P00004M$12,289,100.29
—
Apr 28, 2011FY2011P00003C$550,000.00
—
Jan 14, 2011FY2011P00002M$0.00
—
Dec 22, 2010FY2011P00001B$5,500,000.00
—
Sep 28, 2010FY20100—$6,949,934.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.